Cargando…
iPSCs: A powerful tool for skeletal muscle tissue engineering
Both volumetric muscle loss (VML) and muscle degenerative diseases lead to an important decrease in skeletal muscle mass, condition that nowadays lacks an optimal treatment. This issue has driven towards an increasing interest in new strategies in tissue engineering, an emerging field that can offer...
Autores principales: | del Carmen Ortuño‐Costela, María, García‐López, Marta, Cerrada, Victoria, Gallardo, María Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533516/ https://www.ncbi.nlm.nih.gov/pubmed/30933431 http://dx.doi.org/10.1111/jcmm.14292 |
Ejemplares similares
-
The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019) -
Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014) -
iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017) -
Skeletal muscle differentiation of human iPSCs meets bioengineering strategies: perspectives and challenges
por: Iberite, Federica, et al.
Publicado: (2022) -
Generation of the First Human In Vitro Model for McArdle Disease Based on iPSC Technology
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2022)